Clinical trials
Observational Carotid Stenosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 13 |
| Recruiting | 12 |
| Completed | 4 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xuanwu Hospital, Beijing | 5 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Beijing Tiantan Hospital | 2 |
| Beijing Tsinghua Chang Gung Hospital | 2 |
| Peking Union Medical College Hospital | 2 |
| Beijing Anzhen Hospital | 1 |
| Beijing Friendship Hospital | 1 |
| Changhai Hospital | 1 |
| Chinese PLA General Hospital | 1 |
| First Affiliated Hospital of Harbin Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carotid Stenosis | 32 |
| Ischemic Stroke | 4 |
| Carotid Artery Diseases | 3 |
| Stroke | 3 |
| Atherosclerosis | 2 |
| Plaque, Amyloid | 2 |
| Brain Neoplasms | 1 |
| Cardiovascular Diseases | 1 |
| Cerebral Infarction | 1 |
| Cerebral Small Vessel Diseases | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.